Estimaciones de analistas de Wall Street para Codexis, Inc. (CDXS): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 9 |
| Mantener | 5 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 14 |
| Calificación media (1-5) | 0.64 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.09 | ||
| 2026-08-11 | $-0.13 | $-0.14 | +8.2% |
| 2026-05-07 | $-0.10 | $-0.11 | +9.1% |
| 2026-03-11 | $0.11 | $0.01 | +1000.0% |
| 2025-11-06 | $-0.22 | $-0.15 | -46.7% |
| 2025-08-13 | $-0.16 | $-0.17 | +5.9% |
| 2025-05-14 | $-0.25 | $-0.20 | -25.0% |
| 2025-02-27 | $-0.13 | $-0.04 | -225.0% |
Ratios de valoración
| Precio / Valor contable | 3.70 |
| EV / EBITDA | -9.37 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $48.8M | $50.0M | $60.6M | $68.5M | $69.1M | $104.8M | $138.6M | $70.1M | $59.3M | $70.4M |
| Coste de Ventas | $9.8M | $14.3M | $12.6M | $15.6M | $13.7M | $22.2M | $38.0M | $12.8M | $16.3M | $9.3M |
| Beneficio Bruto | $39.1M | $35.7M | $48.0M | $52.8M | $55.3M | $82.5M | $100.6M | $57.3M | $43.1M | $61.0M |
| I+D | $22.2M | $29.7M | $30.0M | $33.9M | $44.2M | $55.9M | $80.1M | $58.9M | $46.3M | $52.3M |
| Generales y Administrativos | $25.4M | $29.0M | $29.3M | $31.5M | $35.0M | $49.3M | $52.2M | $53.2M | $55.1M | $47.1M |
| Gastos Operativos | $47.6M | $58.7M | $59.3M | $65.4M | $79.2M | $105.2M | $135.4M | $125.4M | $101.6M | $99.4M |
| Beneficio Operativo | -$8.6M | -$23.0M | -$11.3M | -$12.5M | -$23.9M | -$22.7M | -$34.9M | -$68.1M | -$58.5M | -$38.3M |
| EBITDA | -$4.0M | -$21.9M | -$10.1M | -$8.0M | -$19.4M | -$15.1M | -$26.3M | -$49.3M | -$53.4M | -$33.9M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $4.8M |
| Beneficio Antes de Impuestos | -$8.6M | -$22.9M | -$10.9M | -$11.9M | -$23.7M | -$21.1M | -$33.3M | -$76.2M | -$65.2M | -$43.9M |
| Impuestos | -$40000 | $81000 | -$37000 | $17000 | $339000 | $189000 | $276000 | $69000 | $34000 | $47000 |
| Beneficio Neto | -$8.6M | -$23.0M | -$10.9M | -$11.9M | -$24.0M | -$21.3M | -$33.6M | -$76.2M | -$65.3M | -$44.0M |
| BPA | $-0.21 | $-0.50 | $-0.21 | $-0.21 | $-0.40 | $-0.33 | $-0.51 | $-1.12 | $-0.89 | $-0.50 |
| BPA Diluido | $-0.21 | $-0.50 | $-0.21 | $-0.21 | $-0.40 | $-0.33 | $-0.51 | $-1.12 | $-0.89 | $-0.50 |
| Acciones en Circulación (Diluidas) | $40.6M | $46.2M | $52.2M | $56.5M | $59.4M | $64.6M | $65.3M | $68.1M | $73.4M | $87.1M |
Precio
| Precio | $1.34 |
| Capitalización | $144M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ARMP · CCCC · GNFT · IMDX · IPHA · IVVD · OABI
Explorar sector: Healthcare · Biotechnology
Más secciones de CDXS: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones